2021
DOI: 10.7759/cureus.16392
|View full text |Cite
|
Sign up to set email alerts
|

Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic

Abstract: The current COVID-19 pandemic has boosted a sudden demand for telemedicine due to quarantine and travel restrictions. The exponential increase in the use of telemedicine is expected to affect ophthalmology drastically. The aim of this review is to discuss the utility, effectiveness and challenges of teleophthalmological new tools for eyecare delivery as well as its implementation and possible facilitation with artificial intelligence. We used the terms: "teleophthalmology," "telemedicine and COVID-19," "retina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
17
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 106 publications
0
17
0
1
Order By: Relevance
“…Literature has demonstrated a continual evolution of publicly available AI software over multiple iterations. 39 In the present analysis, no assessment was conducted regarding a learning curve or validity and replicability of the responses over time. 15 Given the findings of this study, our aim is to develop a safe methodology for studying the use of publicly available AI software to assist with answering patient questions during the perioperative period for reduction mammaplasty.…”
Section: Discussionmentioning
confidence: 99%
“…Literature has demonstrated a continual evolution of publicly available AI software over multiple iterations. 39 In the present analysis, no assessment was conducted regarding a learning curve or validity and replicability of the responses over time. 15 Given the findings of this study, our aim is to develop a safe methodology for studying the use of publicly available AI software to assist with answering patient questions during the perioperative period for reduction mammaplasty.…”
Section: Discussionmentioning
confidence: 99%
“…Such systems can detect the presence of DR as early as possible, especially for DME or severe or proliferative DR [ 17 , 18 , 19 , 20 , 21 ]. Similarly, uses of new AI technologies applied to DR diagnosis are being developed, driven by the pandemic [ 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Telemedicine has emerged as a game changer and can be used as a novel tool to solve our purpose. [ 22 ]…”
Section: Discussionmentioning
confidence: 99%